rhodioloside has been researched along with Necrosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, Y; Lu, H; Sheng, Z; Zheng, K | 1 |
Chen, J; Hou, R; Jia, X; Jiang, W; Liu, A; Zhang, J | 1 |
2 other study(ies) available for rhodioloside and Necrosis
Article | Year |
---|---|
Salidroside inhibits oxygen glucose deprivation (OGD)/re-oxygenation-induced H9c2 cell necrosis through activating of Akt-Nrf2 signaling.
Topics: Animals; Chromones; Cyclophilins; Gene Expression Regulation; Glucose; Glucosides; Membrane Potential, Mitochondrial; Mitochondria; Morpholines; Myocytes, Cardiac; Necrosis; NF-E2-Related Factor 2; Oxygen; Peptidyl-Prolyl Isomerase F; Phenols; Proto-Oncogene Proteins c-akt; Rats; Reactive Oxygen Species; Signal Transduction; Tumor Suppressor Protein p53 | 2014 |
Salidroside protects cardiomyocyte against hypoxia-induced death: a HIF-1alpha-activated and VEGF-mediated pathway.
Topics: Animals; Apoptosis; Cardiotonic Agents; Cell Hypoxia; Cell Survival; Dose-Response Relationship, Drug; Glucosides; Hypoxia-Inducible Factor 1, alpha Subunit; Myocytes, Cardiac; Necrosis; Phenols; Protein Transport; Rats; Rats, Sprague-Dawley; Rhodiola; Up-Regulation; Vascular Endothelial Growth Factor A | 2009 |